{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:37Z","timestamp":1786985017930,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the NIH"},{"name":"Center for Cancer Research"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbmt.2016.08.028","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T12:37:20Z","timestamp":1473770240000},"page":"2149-2154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse"],"prefix":"10.1016","volume":"22","author":[{"given":"Nirali N.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hahn","family":"Khuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolu","family":"Ariyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Delbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Mackall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.08.028_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0020","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.bbmt.2013.08.016","article-title":"Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction","volume":"19","author":"Wayne","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2013.08.012","volume":"20","author":"de Lima","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0045(199601)28:1<65::AID-PROS9>3.0.CO;2-N","article-title":"Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity","volume":"28","author":"Tjoa","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0040","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","article-title":"Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia","volume":"89","author":"Inoue","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0045","first-page":"1060","article-title":"Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias","volume":"9","author":"Menssen","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/15258160260194749","article-title":"A review of the Wilms' tumor 1 gene (WT1) and its role in hematopoiesis and leukemia","volume":"11","author":"Algar","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02982571","article-title":"Wilms tumor gene (WT1) expression as a panleukemic marker","volume":"76","author":"Menssen","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.pai.0000143786.62974.66","article-title":"Differential expression of WT1 gene product in non-Hodgkin lymphomas","volume":"13","author":"Drakos","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/hmg\/11.6.651","article-title":"WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis","volume":"11","author":"Guo","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0070","first-page":"945","article-title":"The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro","volume":"25","author":"Maurer","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0075","doi-asserted-by":"crossref","first-page":"13824","DOI":"10.1073\/pnas.1008051107","article-title":"Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination","volume":"107","author":"Van Tendeloo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2015.00036","article-title":"Review of the results of WT1 peptide vaccination strategies for myelodysplastic syndromes and acute myeloid leukemia from nine different studies","volume":"6","author":"Di Stasi","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jcyt.2014.10.003","article-title":"Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1-specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature","volume":"17","author":"Saito","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21127","article-title":"Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia","volume":"83","author":"Kitawaki","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pbc.25792","article-title":"Feasibility of cancer immunotherapy with WT1 peptide vaccination for solid and hematological malignancies in children","volume":"63","author":"Sawada","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/leu.2011.226","article-title":"WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission","volume":"26","author":"Hashii","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/146532401753156377","article-title":"Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy","volume":"3","author":"Wong","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0110","first-page":"921","article-title":"Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/meth.2001.1186","article-title":"TAT-mediated protein transduction into mammalian cells","volume":"24","author":"Becker-Hapak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0120","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.168.5.2393","article-title":"Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity","volume":"168","author":"Shibagaki","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0125","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1172\/JCI200215399","article-title":"Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells","volume":"109","author":"Wang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","article-title":"Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen","volume":"88","author":"Cardoso","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0135","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOT.0000000000000204","article-title":"Role of B cells in tolerance induction","volume":"20","author":"Kim","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0140","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2007-03-076844","article-title":"Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia","volume":"110","author":"Rezvani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0145","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2014-12-615757","article-title":"IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients","volume":"125","author":"Pulsipher","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.08.028_bib0150","unstructured":"The Central Data Analysis Committee. Allele frequencies SSCFLITDBottIHY-."},{"key":"10.1016\/j.bbmt.2016.08.028_bib0155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14653240902960411","article-title":"Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial","volume":"11","author":"Van Driessche","year":"2009","journal-title":"Cytotherapy"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911630324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911630324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:56:13Z","timestamp":1761058573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911630324X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S108387911630324X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.08.028","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}